Diabetic Eye Disease

News about diabetic eye disease from Harvard Medical School Department of Ophthalmology

Lloyd P. Aiello, MD, PhD to Receive Friedenwald Award

February 12, 2020

Lloyd P. Aiello, MD, PhD, has been named the 2020 recipient of the prestigious Friedenwald Award from the Association for Research in Vision and Ophthalmology (ARVO). The Friedenwald Award was established in 1957 as a memorial to Dr. Jonas S. Friedenwald, a distinguished researcher whose contributions encompassed the entire field of ophthalmic investigations.... Read more about Lloyd P. Aiello, MD, PhD to Receive Friedenwald Award

Lloyd Paul Aiello Inducted Into Retina Hall of Fame

November 6, 2019

 

Lloyd Paul Aiello,  MD, PhD, Professor of Ophthalmology and Co-Director of the Diabetic Eye Disease Center of Excellence at Harvard Medical School, has been inducted into the Retina Hall of Fame for his contributions to the research and treatment of diabetic retinopathy. The Retina Hall of Fame was established in 2016 to honor the significant achievements and contributions of leaders in the field.... Read more about Lloyd Paul Aiello Inducted Into Retina Hall of Fame

Konstantina Sampani Receives 2019 Science Communications Training Fellowship

March 15, 2019

sampani_k

Konstantina Sampani, MD, Clinical Research Fellow at The Beetham Eye Institute at Joslin Diabetes Center, received ARVO's 2019 Science Communications Training Fellowship. The one year program - awarded to just 20 ARVO members - trains young scientists to become more effective communicators of vision research to all audiences.... Read more about Konstantina Sampani Receives 2019 Science Communications Training Fellowship

Researchers identify new target for abnormal blood vessel growth in the eyes

April 11, 2017

Regulating transcription factor RUNX1 using small molecule drugs a promising novel therapy for diseases of the retina, including advanced diabetic eye disease.

Boston, Mass.— A team led by Massachusetts Eye and Ear researchers has identified a novel therapeutic target for retinal neovascularization, or abnormal blood vessel growth in the retina, a hallmark of advanced diabetic eye disease (proliferative diabetic retinopathy).... Read more about Researchers identify new target for abnormal blood vessel growth in the eyes

Growth factor shown to protect the retina in early stage diabetes

Growth factor shown to protect the retina in early stage diabetes

February 3, 2017

New research findings may lead to development of new therapies to delay or prevent the development of diabetic eye disease.

Boston, Mass. — Researchers from the Schepens Eye Research Institute of Massachusetts Eye and Ear have shown that a slight increase in transforming growth factor beta (TGF-β), which is present in preclinical animal models with diabetic eye disease, protects retinal blood vessels from damage that commonly occurs in the early stages of the disease (known as diabetic retinopathy). Their findings, ...

Read more about Growth factor shown to protect the retina in early stage diabetes
Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

Researchers identify candidate biomarker of accelerated onset diabetic retinopathy

April 1, 2016

 

Mass. Eye and Ear researchers describe, for the first time, an association between a defective myogenic response of blood vessels in the retina and early, accelerated development of retinopathy in patients with type 1 diabetes. The findings may lead to the development of targeted therapies to delay or prevent the development of diabetic retinopathy in this population.

(BOSTON) – Researchers from Massachusetts Eye and Ear and...

Read more about Researchers identify candidate biomarker of accelerated onset diabetic retinopathy
Lloyd Paul Aiello

Comparing Diabetic Macular Edema Treatments

February 19, 2015

Results of the DRCR.net Protocol T Study 

In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in improving vision and preventing vision loss. However, one drug, aflibercept, provided greater improvement for people with more severe vision loss when treatment was initiated. The trial was conducted by the...

Read more about Comparing Diabetic Macular Edema Treatments